Clinical Trials Directory

Trials / Completed

CompletedNCT06377787

Effects of ELDOA in Patients With Cervicogenic Headache

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Riphah International University · Academic / Other
Sex
All
Age
30 Years – 45 Years
Healthy volunteers
Not accepted

Summary

The aim of our study is to determine the effect of ELDOA in relieving pain, improving ROM and functional disability in patients with cervicogenic headache. This study will add to the growing body of knowledge that if this technique yields comparable outcomes, it would be the alternative therapy. Moreover, it would add to the society as no literature is available on the effect of ELDOA technique in the management of Cervicogenic headache.

Detailed description

Cervicogenic Headache (CEH) is mainly caused by neck or paravertebral soft tissue lesions. It is chronic headache that arises from the Atlanto-occipital and upper cervical joints and is perceived in one or more regions of the head or face. One of the known treatment options that create decompression at spinal segment level is called ELDOA it is described as a conditioning method involving a series of movements and body stretches to help correct body posture, rehabilitate people with injuries and prevent injuries

Conditions

Interventions

TypeNameDescription
OTHERELDOA and conventional therapyhot pack and TENS for10 min, cervical PIR (MET) in flexion, extension, side bending and rotation (single set of 4rep with 6 sec hold once a day) and ELDOA method C0-C1-C2, C2 \& C3 positions for cervical spine (2 sets of five repetitions with 45 sec hold and 15sec rest between each set once a day).
OTHERconventional therapyinclude hot pack and TENS for 10 minutes, cervical PIR (MET) in flexion, extension, side bending and rotation (single set of 4 reps with 6 seconds hold once a day).

Timeline

Start date
2024-04-02
Primary completion
2024-06-10
Completion
2024-07-01
First posted
2024-04-22
Last updated
2024-07-23

Locations

1 site across 1 country: Pakistan

Source: ClinicalTrials.gov record NCT06377787. Inclusion in this directory is not an endorsement.